Pediatric T-cell lymphoblastic lymphoma with t(9;17)(q34;q23)-associated N-terminally truncated NOTCH1 activation: a case report.

Int J HematolSep 2, 2026 (epub)

Ayako Yamamori, Daichi Sajiki, Yusuke Tsumura et al.

✦ AI-curated · Sources linked

Case in brief

A 6-year-old boy presented with T-cell lymphoblastic lymphoma (T-LBL). Testing identified a t(9;17)(q34;q23) translocation producing a MIR142HG::NOTCH1 fusion and a truncated, constitutively active NOTCH1 protein. His disease followed an aggressive course, and he died shortly after cord blood transplantation.

What made this case unusual

The structural NOTCH1 rearrangement generated an N-terminally truncated, constitutively active protein, unlike the point mutations or small indels commonly described in T-LBL.

Diagnostic / clinical pearl

In T-LBL, structural NOTCH1 rearrangements can produce truncated, constitutively active NOTCH1; identifying the alteration may be relevant to understanding disease biology and potential therapeutic targets.

Why it matters

The authors’ literature review suggests that 9q34 translocations in T-LBL may be associated with poor prognosis, although the clinical impact of structural NOTCH1 rearrangements remains poorly understood.

Source

Published in Int J Hematol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.